Disease_category,Disease,Protein,Protein_definition,NB_individual,NB_case,HR[95%CI],P_value
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,ACE2,Angiotensin-converting enzyme 2,22307,105,1.43 [1.08-1.87],0.0113518394847973
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,ACOX1,Peroxisomal acyl-coenzyme A oxidase 1,22722,109,1.39 [1.04-1.86],0.0271354872027071
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,ACP1,Low molecular weight phosphotyrosine protein phosphatase,19176,84,0.51 [0.30-0.86],0.0119157089125741
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,ACP6,Lysophosphatidic acid phosphatase type 6,22890,109,0.78 [0.63-0.97],0.024097513707289
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,ACTA2,"Actin, aortic smooth muscle",22307,105,1.53 [1.13-2.07],0.005821117520115
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,ACVRL1,Serine/threonine-protein kinase receptor R3,22480,108,2.10 [1.16-3.83],0.015067338791405
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,ADAM12,Disintegrin and metalloproteinase domain-containing protein 12,19176,84,1.82 [1.05-3.15],0.0338074631342938
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,ADAM15,Disintegrin and metalloproteinase domain-containing protein 15,22307,105,1.90 [1.10-3.28],0.0204717337560086
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,ADAMTSL2,ADAMTS-like protein 2,19775,88,1.78 [1.05-2.99],0.0307434673941899
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,ADD1,Alpha-adducin,19321,84,0.70 [0.52-0.95],0.0209804640729525
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,ADGRG2,Adhesion G-protein coupled receptor G2,22722,109,0.60 [0.36-1.00],0.0491272374935306
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,ADIPOQ,Adiponectin,19786,88,1.69 [1.27-2.26],0.0003659111339432
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,ADM,Pro-adrenomedullin,22917,109,2.45 [1.28-4.69],0.0070634611915639
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,AGRN,Agrin,22802,107,1.74 [1.16-2.60],0.0077683754813107
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,AIDA,"Axin interactor, dorsalization-associated protein",19237,83,0.69 [0.49-0.98],0.0360244109663167
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,ALCAM,CD166 antigen,23006,109,2.29 [1.01-5.19],0.0468711300901401
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,AMOT,Angiomotin,19321,84,0.54 [0.30-0.96],0.0361497616447062
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,ANGPT2,Angiopoietin-2,22917,109,2.27 [1.53-3.38],4.605106808144189e-05
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,ANGPTL1,Angiopoietin-related protein 1,22362,107,2.41 [1.35-4.31],0.0029202588218887
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,ANGPTL4,Angiopoietin-related protein 4,22768,107,2.26 [1.56-3.28],1.7018716328866838e-05
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,AP2B1,AP-2 complex subunit beta,19237,83,0.59 [0.36-0.98],0.0434996036644571
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,APCS,Serum amyloid P-component,19611,86,0.50 [0.27-0.93],0.0297763996007346
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,APOA4,Apolipoprotein A-IV,19786,88,1.65 [1.02-2.69],0.043218666396195
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,AREG,Amphiregulin,22609,108,2.14 [1.51-3.02],1.617644016816147e-05
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,ARHGAP30,Rho GTPase-activating protein 30,19421,86,0.39 [0.17-0.90],0.0264805779239251
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,ATXN3,Ataxin-3,19716,86,0.70 [0.50-0.98],0.0396017420376936
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,B2M,Beta-2-microglobulin,19786,88,1.48 [1.01-2.16],0.0416640535810344
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,B4GALT1,"Beta-1,4-galactosyltransferase 1",22802,107,2.66 [1.52-4.64],0.0005978967942209
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,BCAM,Basal cell adhesion molecule,22727,108,2.42 [1.27-4.64],0.0074901105612198
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,BCAN,Brevican core protein,22521,108,0.59 [0.37-0.96],0.033842567630085
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,BCAT2,"Branched-chain-amino-acid aminotransferase, mitochondrial",19125,83,0.58 [0.34-0.99],0.0463178392751747
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,BCHE,Cholinesterase,19423,86,0.38 [0.19-0.73],0.0035547952165735
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,BCL7B,B-cell CLL/lymphoma 7 protein family member B,19698,87,0.52 [0.29-0.92],0.026211538550051
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,BOC,Brother of CDO,22307,105,2.21 [1.05-4.64],0.0362122754311564
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,BTN2A1,Butyrophilin subfamily 2 member A1,22802,107,1.85 [1.05-3.26],0.0339434931253252
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,C1QA,Complement C1q subcomponent subunit A,22881,108,2.91 [1.46-5.80],0.002338604007115
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,C1R,Complement C1r subcomponent,19786,88,2.24 [1.11-4.49],0.0236751782234524
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,C7,Complement component C7,19307,86,3.46 [1.94-6.17],2.6625691176710247e-05
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,CA8,Carbonic anhydrase-related protein,19176,84,1.74 [1.11-2.73],0.0158175972061595
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,CALB1,Calbindin,22609,108,1.51 [1.04-2.17],0.0280965527910147
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,CALB2,Calretinin,22218,108,1.41 [1.04-1.91],0.0246638137032905
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,CAPG,Macrophage-capping protein,22566,108,1.37 [1.05-1.79],0.0221743471537976
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,CAPN3,Calpain-3,19698,87,1.50 [1.05-2.15],0.0275364765715976
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,CCDC80,Coiled-coil domain-containing protein 80,22722,109,2.36 [1.59-3.49],1.871275799773577e-05
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,CCER2,Coiled-coil domain-containing glutamate-rich protein 2,19224,81,1.42 [1.04-1.93],0.0275213668068738
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,CCL15,C-C motif chemokine 15,23006,109,1.49 [1.05-2.12],0.0254132254058474
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,CCL21,C-C motif chemokine 21,22802,107,1.68 [1.22-2.31],0.001397374379933
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,CCL25,C-C motif chemokine 25,22990,109,1.49 [1.05-2.10],0.0240058525891368
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,CCL26,C-C motif chemokine 26,22700,107,0.79 [0.64-0.98],0.0296141262317215
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,CD276,CD276 antigen,22689,107,2.34 [1.44-3.80],0.0005915986473187
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,CD300LG,CMRF35-like molecule 9,22727,108,1.63 [1.04-2.54],0.0313214511090509
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,CD302,CD302 antigen,22609,108,1.77 [1.09-2.89],0.0219894374243915
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,CD5L,CD5 antigen-like,19690,87,1.54 [1.02-2.34],0.0422449684373437
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,CD7,T-cell antigen CD7,19144,84,1.72 [1.14-2.57],0.0091133667136964
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,CD79B,B-cell antigen receptor complex-associated protein beta chain,22990,109,1.45 [1.04-2.02],0.0289062690763356
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,CD93,Complement component C1q receptor,21896,102,1.75 [1.03-2.98],0.0390149748283591
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,CD99,CD99 antigen,22727,108,2.68 [1.22-5.91],0.0141715354974808
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,CDA,Cytidine deaminase,19737,87,0.63 [0.40-0.99],0.0445620461913381
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,CDH6,Cadherin-6,22722,109,1.57 [1.04-2.38],0.0336804077108536
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,CEACAM16,Carcinoembryonic antigen-related cell adhesion molecule 16,19704,87,0.74 [0.58-0.95],0.0191177335299967
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,CEACAM8,Carcinoembryonic antigen-related cell adhesion molecule 8,22307,105,1.59 [1.18-2.15],0.002548583222525
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,CENPF,Centromere protein F,19421,86,0.65 [0.43-0.98],0.0420848078834578
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,CEP170,Centrosomal protein of 170 kDa,19224,81,0.72 [0.52-0.99],0.0402968373712973
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,CFD,Complement factor D,19786,88,2.17 [1.09-4.31],0.027070014876399
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,CGA,Glycoprotein hormones alpha chain,22727,108,1.32 [1.02-1.69],0.0326033118187167
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,CHCHD10,"Coiled-coil-helix-coiled-coil-helix domain-containing protein 10, mitochondrial",19716,86,1.95 [1.30-2.92],0.0012072220770425
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,CHI3L1,Chitinase-3-like protein 1,22248,105,1.28 [1.07-1.54],0.0077177212208752
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,CILP,Cartilage intermediate layer protein 1,19775,88,1.58 [1.07-2.32],0.0219400940375897
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,CINP,Cyclin-dependent kinase 2-interacting protein,19421,86,0.47 [0.26-0.87],0.0162681646769133
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,CKAP4,Cytoskeleton-associated protein 4,22877,108,2.21 [1.43-3.43],0.000386018897632
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,CKB,Creatine kinase B-type,19775,88,2.06 [1.48-2.86],1.935356035566153e-05
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,CLEC10A,C-type lectin domain family 10 member A,22521,108,0.62 [0.39-0.99],0.045069291127305
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,CLEC14A,C-type lectin domain family 14 member A,22727,108,1.91 [1.17-3.11],0.0092451559315798
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,CLEC4D,C-type lectin domain family 4 member D,22700,107,1.36 [1.05-1.76],0.0185727624993098
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,CLEC5A,C-type lectin domain family 5 member A,22646,109,2.27 [1.36-3.79],0.0017183089271199
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,CLMP,CXADR-like membrane protein,22917,109,2.84 [1.46-5.55],0.0021970523416253
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,CLNS1A,Methylosome subunit pICln,19237,83,0.42 [0.21-0.86],0.0172770057895642
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,CLSTN2,Calsyntenin-2,22990,109,2.13 [1.55-2.92],2.784764282465258e-06
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,CLU,Clusterin,19786,88,1.77 [1.24-2.55],0.0018978882105069
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,COL18A1,Collagen alpha-1(XVIII) chain,22818,109,2.72 [1.38-5.38],0.0039498626546428
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,COL4A1,Collagen alpha-1(IV) chain,22722,109,1.93 [1.31-2.85],0.0009393966733006
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,COL6A3,Collagen alpha-3(VI) chain,23006,109,2.10 [1.41-3.13],0.0002870935204661
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,COL9A2,Collagen alpha-2(IX) chain,19421,86,0.51 [0.29-0.92],0.0248896040850353
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,COLEC12,Collectin-12,22689,107,2.04 [1.15-3.63],0.0148633901137111
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,CORO6,Coronin-6,19125,83,1.82 [1.24-2.66],0.0021644318960913
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,CPXM2,Inactive carboxypeptidase-like protein X2,19770,87,2.47 [1.22-5.02],0.0120384170730133
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,CRIM1,Cysteine-rich motor neuron 1 protein,22802,107,2.85 [1.29-6.34],0.009933964784865
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,CSF1,Macrophage colony-stimulating factor 1,22802,107,3.04 [1.72-5.37],0.0001253414868702
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,CSRP3,Cysteine and glycine-rich protein 3,19095,82,1.23 [1.03-1.47],0.0236167387402237
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,CST3,Cystatin-C,22792,108,1.91 [1.13-3.21],0.0148997237540872
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,CST7,Cystatin-F,22727,107,1.22 [1.06-1.40],0.0061811631484923
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,CTSB,Cathepsin B,22745,109,1.50 [1.10-2.03],0.0094124967902537
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,CTSS,Cathepsin S,17890,89,2.56 [1.11-5.92],0.0282095429426426
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,CXADR,Coxsackievirus and adenovirus receptor,22700,107,1.53 [1.11-2.10],0.00929918837874
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,CXCL16,C-X-C motif chemokine 16,22970,109,3.40 [1.72-6.71],0.0004232009523007
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,CXCL17,C-X-C motif chemokine 17,22990,109,1.48 [1.04-2.11],0.0310849413978169
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,DAAM1,Disheveled-associated activator of morphogenesis 1,19321,84,0.74 [0.56-0.96],0.0248581290954603
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,DDA1,DET1- and DDB1-associated protein 1,19095,82,0.50 [0.25-0.98],0.0441029781281212
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,DDI2,Protein DDI1 homolog 2,19321,84,0.74 [0.56-0.98],0.0383851170241633
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,DDR1,Epithelial discoidin domain-containing receptor 1,22930,109,2.07 [1.05-4.07],0.0361391131388396
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,DEFB118,Beta-defensin 118,19125,83,1.42 [1.14-1.77],0.001703318348362
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,DKK4,Dickkopf-related protein 4,22480,108,1.43 [1.02-1.99],0.0364718503890248
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,DLG4,Disks large homolog 4,19716,86,0.69 [0.50-0.94],0.0202759893982954
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,DLL1,Delta-like protein 1,22780,108,1.76 [1.05-2.95],0.0332808605704497
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,DPT,Dermatopontin,23006,109,2.59 [1.27-5.26],0.0086834306323235
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,DSC2,Desmocollin-2,22446,107,2.01 [1.28-3.17],0.0026171648911132
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,DSG2,Desmoglein-2,22727,108,2.20 [1.22-3.96],0.0085065805551368
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,DSG3,Desmoglein-3,22842,109,1.60 [1.00-2.55],0.0476731325781987
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,DTNB,Dystrobrevin beta,19654,87,1.60 [1.05-2.43],0.0289732455776434
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,DTX3,Probable E3 ubiquitin-protein ligase DTX3,22609,108,2.43 [1.40-4.21],0.0016046232629464
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,EBI3_IL27,Interleukin-27,22890,109,1.87 [1.10-3.18],0.0211553927390806
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,ECSCR,Endothelial cell-specific chemotaxis regulator,19125,83,0.42 [0.22-0.82],0.01095874571914
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,EDA2R,Tumor necrosis factor receptor superfamily member 27,22917,109,2.37 [1.65-3.41],3.01796622048717e-06
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,EDN1,Endothelin-1,19224,81,2.55 [1.33-4.88],0.0048511701499869
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,EEF1D,Elongation factor 1-delta,19770,87,0.75 [0.59-0.95],0.0166571894773487
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,EFEMP1,EGF-containing fibulin-like extracellular matrix protein 1,22797,108,1.99 [1.21-3.28],0.0064811796741999
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,EFNA1,Ephrin-A1,22687,108,2.07 [1.24-3.44],0.0051576929436771
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,EFNA4,Ephrin-A4,22480,108,1.68 [1.05-2.69],0.0312923618645036
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,ELN,Elastin,19770,87,2.31 [1.32-4.05],0.0033003358822958
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,ENAH,Protein enabled homolog,22323,107,1.53 [1.12-2.09],0.0073871029156191
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,ENDOU,Poly(U)-specific endoribonuclease,18249,79,1.44 [1.00-2.07],0.048065590988975
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,ENTPD6,Ectonucleoside triphosphate diphosphohydrolase 6,22307,105,2.16 [1.06-4.40],0.0334151904738559
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,ENTR1,Endosome-associated-trafficking regulator 1,19224,81,0.51 [0.33-0.79],0.0025704477441134
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,EPHA2,Ephrin type-A receptor 2,21876,102,2.28 [1.44-3.62],0.0004762869492131
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,EPHB4,Ephrin type-B receptor 4,23006,109,2.03 [1.11-3.71],0.0211881983311357
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,EPHB6,Ephrin type-B receptor 6,22488,108,2.01 [1.24-3.26],0.0049170160727878
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,EPN1,Epsin-1,19421,86,0.50 [0.26-0.96],0.0358441700884789
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,EVI2B,Protein EVI2B,19082,85,1.51 [1.08-2.11],0.0155008880926817
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,F11,Coagulation factor XI,19507,86,1.54 [1.02-2.31],0.0382563949989062
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,FABP1,"Fatty acid-binding protein, liver",22689,107,1.20 [1.01-1.42],0.0384449754941471
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,FABP3,"Fatty acid-binding protein, heart",19770,87,1.53 [1.11-2.11],0.0093785362602278
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,FABP4,"Fatty acid-binding protein, adipocyte",23006,109,1.71 [1.27-2.30],0.0003813001851573
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,FAM3C,Protein FAM3C,22691,109,1.97 [1.17-3.32],0.0105718208192877
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,FARSA,Phenylalanine--tRNA ligase alpha subunit,19237,83,0.63 [0.43-0.91],0.0144017623635342
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,FCRL2,Fc receptor-like protein 2,22883,109,1.34 [1.00-1.79],0.0468226114441174
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,FCRLB,Fc receptor-like B,22178,107,1.30 [1.05-1.60],0.0153369752604547
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,FGF16,Fibroblast growth factor 16,19176,84,0.54 [0.31-0.92],0.0235857136688989
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,FGF23,Fibroblast growth factor 23,22879,109,1.37 [1.07-1.76],0.0126386468633181
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,FGFR2,Fibroblast growth factor receptor 2,22780,108,2.12 [1.06-4.26],0.0341443947118492
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,FGL1,Fibrinogen-like protein 1,19789,88,1.46 [1.09-1.96],0.0118856365864051
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,FGR,Tyrosine-protein kinase Fgr,22218,108,1.24 [1.00-1.54],0.0482495004254099
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,FHIP2A,FHF complex subunit HOOK interacting protein 2A,19095,82,0.53 [0.31-0.90],0.0194440914435126
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,FLRT2,Leucine-rich repeat transmembrane protein FLRT2,22521,108,2.07 [1.21-3.55],0.007944000263867
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,FLT1,Vascular endothelial growth factor receptor 1,22570,108,2.03 [1.16-3.56],0.0133416336043853
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,FOLR2,Folate receptor beta,22930,109,1.89 [1.07-3.32],0.027039548661574
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,FSTL3,Follistatin-related protein 3,22658,107,2.40 [1.53-3.76],0.000128257215058
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,GALNT2,Polypeptide N-acetylgalactosaminyltransferase 2,22917,109,0.54 [0.29-1.00],0.0482161986213465
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,GASK1A,Golgi-associated kinase 1A,19095,82,0.59 [0.36-0.97],0.0363207327207397
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,GCG,Pro-glucagon,22178,107,1.15 [1.01-1.32],0.0399805829964123
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,GDF15,Growth/differentiation factor 15,23006,109,2.17 [1.69-2.80],1.86509994336816e-09
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,GFAP,Glial fibrillary acidic protein,22140,106,1.83 [1.31-2.56],0.0004238537319659
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,GFRA1,GDNF family receptor alpha-1,22890,109,2.67 [1.59-4.48],0.0001998794995759
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,GIP,Gastric inhibitory polypeptide,19224,81,1.59 [1.12-2.26],0.0091709409693629
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,GIPC2,PDZ domain-containing protein GIPC2,19716,86,1.94 [1.06-3.54],0.03157875283496
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,GLA,Alpha-galactosidase A,19290,84,0.59 [0.35-0.99],0.0468467716434047
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,GM2A,Ganglioside GM2 activator,19297,86,1.54 [1.10-2.16],0.0121193389945679
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,GP2,Pancreatic secretory granule membrane major glycoprotein GP2,22018,105,1.32 [1.11-1.58],0.0018187332367093
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,GPR37,Prosaposin receptor GPR37,22307,105,1.33 [1.02-1.74],0.0327097897004314
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,GZMB,Granzyme B,22700,107,0.69 [0.51-0.92],0.0125871890568578
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,HAVCR1,Hepatitis A virus cellular receptor 1,22883,109,1.31 [1.03-1.67],0.0299660277573161
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,HAVCR2,Hepatitis A virus cellular receptor 2,22727,108,1.61 [1.03-2.52],0.0373605199051882
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,HDAC8,Histone deacetylase 8,19176,84,0.54 [0.31-0.94],0.029325940775479
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,HGF,Hepatocyte growth factor,22990,109,2.16 [1.43-3.29],0.000286591589869
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,HSD17B3,Testosterone 17-beta-dehydrogenase 3,19095,82,0.59 [0.35-0.99],0.0467760139251755
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,HSPB6,Heat shock protein beta-6,22917,109,2.00 [1.39-2.88],0.000203488848486
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,HTR1B,5-hydroxytryptamine receptor 1B,19125,83,0.47 [0.25-0.87],0.0171979483442062
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,IDI2,Isopentenyl-diphosphate delta-isomerase 2,22218,108,1.43 [1.06-1.93],0.0179142913344488
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,IFNGR1,Interferon gamma receptor 1,22802,107,2.19 [1.13-4.22],0.0198398857251511
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,IFNW1,Interferon omega-1,19095,82,1.56 [1.09-2.22],0.0141440690792442
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,IGF2R,Cation-independent mannose-6-phosphate receptor,22727,108,2.19 [1.08-4.43],0.0302096502634744
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,IGFBP1,Insulin-like growth factor-binding protein 1,22972,109,1.16 [1.01-1.33],0.0358382724492342
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,IGFBP2,Insulin-like growth factor-binding protein 2,22972,109,1.99 [1.51-2.63],1.2498054712104978e-06
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,IGFBP4,Insulin-like growth factor-binding protein 4,22452,108,1.85 [1.37-2.49],5.975090977048155e-05
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,IGFBP7,Insulin-like growth factor-binding protein 7,23006,109,1.76 [1.16-2.65],0.0075284367484524
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,IGFBPL1,Insulin-like growth factor-binding protein-like 1,22722,109,1.74 [1.11-2.73],0.0150989608720237
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,IGLC2,Immunoglobulin lambda constant 2,19760,88,1.83 [1.16-2.90],0.0095994895311492
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,IL15,Interleukin-15,22700,107,2.42 [1.54-3.81],0.0001241425888617
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,IL17C,Interleukin-17C,22323,107,1.26 [1.03-1.55],0.026628672913405
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,IL19,Interleukin-19,22160,106,1.26 [1.02-1.56],0.0301515346767576
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,IL1B,Interleukin-1 beta,22214,105,1.51 [1.19-1.91],0.0007391940819731
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,IL1R1,Interleukin-1 receptor type 1,22687,108,3.01 [1.57-5.76],0.0008578451840351
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,IL1RL2,Interleukin-1 receptor-like 2,22323,107,0.61 [0.39-0.95],0.0279251346625137
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,IL1RN,Interleukin-1 receptor antagonist protein,22647,107,1.41 [1.08-1.85],0.0124515047120043
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,IL2RA,Interleukin-2 receptor subunit alpha,22577,108,1.53 [1.06-2.21],0.0235197491088737
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,IL2RG,Cytokine receptor common subunit gamma,19698,87,1.65 [1.09-2.50],0.0171088610872638
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,IL4R,Interleukin-4 receptor subunit alpha,22700,107,1.80 [1.19-2.72],0.0055508434384636
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,IL5RA,Interleukin-5 receptor subunit alpha,22700,107,1.35 [1.01-1.79],0.0392822321557197
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,IL6,Interleukin-6,22609,108,1.29 [1.09-1.53],0.0028657040020974
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,IL6ST,Interleukin-6 receptor subunit beta,22722,109,2.59 [1.05-6.43],0.0395889130540591
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,ITGA11,Integrin alpha-11,22700,107,0.54 [0.33-0.89],0.0157924470769597
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,ITGA2,Integrin alpha-2,19321,84,0.46 [0.25-0.83],0.0102915047064655
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,ITIH3,Inter-alpha-trypsin inhibitor heavy chain H3,22832,108,1.91 [1.22-2.99],0.0045960387863118
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,KCTD5,BTB/POZ domain-containing protein KCTD5,19343,85,0.59 [0.35-0.99],0.0463231126394742
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,KIAA1549,UPF0606 protein KIAA1549,19421,86,0.72 [0.54-0.96],0.0233103839166716
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,KLK11,Kallikrein-11,22560,107,1.60 [1.07-2.39],0.0217909331265834
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,KLK12,Kallikrein-12,22178,107,0.83 [0.74-0.94],0.0042039259612913
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,KLK4,Kallikrein-4,22917,109,1.54 [1.24-1.91],9.483918506416582e-05
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,LAMP3,Lysosome-associated membrane glycoprotein 3,22952,108,1.57 [1.15-2.15],0.0045231972514722
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,LDLR,Low-density lipoprotein receptor,22787,109,0.64 [0.45-0.90],0.0097670800947959
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,LGALS7_LGALS7B,Galectin-7,22656,108,1.50 [1.11-2.01],0.0080287632843303
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,LIFR,Leukemia inhibitory factor receptor,22700,107,2.74 [1.45-5.17],0.001899003004363
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,LILRB4,Leukocyte immunoglobulin-like receptor subfamily B member 4,22323,107,1.45 [1.00-2.09],0.0494351933930645
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,LMOD1,Leiomodin-1,19729,85,2.41 [1.71-3.40],5.019104977397363e-07
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,LRG1,Leucine-rich alpha-2-glycoprotein,19786,88,2.38 [1.15-4.95],0.0200188383418589
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,LRP11,Low-density lipoprotein receptor-related protein 11,22722,109,1.70 [1.10-2.63],0.015949955699283
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,LRRN1,Leucine-rich repeat neuronal protein 1,22323,107,0.54 [0.35-0.82],0.0037682216957236
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,LRTM1,Leucine-rich repeat and transmembrane domain-containing protein 1,19237,83,1.52 [1.07-2.16],0.0181128362670534
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,LTBP2,Latent-transforming growth factor beta-binding protein 2,23006,109,2.41 [1.49-3.89],0.0003091172711071
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,LTBR,Tumor necrosis factor receptor superfamily member 3,22570,107,2.29 [1.39-3.76],0.0010838691248103
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,LY6D,Lymphocyte antigen 6D,22575,107,1.51 [1.04-2.21],0.0313155496987923
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,MAGEA3,Melanoma-associated antigen 3,19421,86,0.81 [0.68-0.98],0.027658944598416
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,MAMDC2,MAM domain-containing protein 2,19770,87,1.93 [1.12-3.33],0.0170673903593734
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,MANSC1,MANSC domain-containing protein 1,22780,108,1.89 [1.06-3.39],0.0312912135341513
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,MAP1LC3B2,Microtubule-associated proteins 1A/1B light chain 3 beta 2,19095,82,1.31 [1.06-1.62],0.0108693285359659
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,MAPT,Microtubule-associated protein tau,22218,108,1.43 [1.01-2.03],0.0457835513488265
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,MATN2,Matrilin-2,22723,107,2.05 [1.15-3.63],0.0143124269388683
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,MFAP3L,Microfibrillar-associated protein 3-like,19237,83,0.58 [0.36-0.96],0.0341259023408709
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,MMP7,Matrilysin,22276,105,1.48 [1.04-2.13],0.0308632777310263
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,MMP8,Neutrophil collagenase,22893,109,1.47 [1.21-1.80],0.0001458140525694
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,MMP9,Matrix metalloproteinase-9,22695,108,1.58 [1.19-2.09],0.001316522373057
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,MPO,Myeloperoxidase,22727,108,1.53 [1.13-2.08],0.0060545520321239
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,MRC1,Macrophage mannose receptor 1,19789,88,2.01 [1.01-4.02],0.0472641096744067
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,MYBPC1,"Myosin-binding protein C, slow-type",19770,87,1.34 [1.06-1.71],0.0148520657283243
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,MYOM3,Myomesin-3,19321,84,1.28 [1.03-1.58],0.0250075943087358
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,NAGA,Alpha-N-acetylgalactosaminidase,19144,84,0.55 [0.33-0.93],0.0266182782766046
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,NAGK,N-acetyl-D-glucosamine kinase,19192,81,0.56 [0.37-0.83],0.0045457338782946
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,NBL1,Neuroblastoma suppressor of tumorigenicity 1,22780,108,2.36 [1.32-4.20],0.0036435881275473
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,NCAM2,Neural cell adhesion molecule 2,22727,108,1.96 [1.05-3.66],0.0357201317244275
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,NCS1,Neuronal calcium sensor 1,22917,109,2.47 [1.40-4.35],0.0017474111060008
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,NEFL,Neurofilament light polypeptide,22152,108,1.81 [1.33-2.47],0.0001784286746496
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,NFAT5,Nuclear factor of activated T-cells 5,19176,84,0.72 [0.54-0.96],0.0278581025128993
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,NFKB2,Nuclear factor NF-kappa-B p100 subunit,19421,86,0.50 [0.26-0.96],0.0370900135266641
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,NINJ1,Ninjurin-1,22178,107,0.63 [0.40-0.98],0.0385680547569621
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,NOP56,Nucleolar protein 56,19095,82,0.72 [0.54-0.96],0.022662383182025
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,NOTCH3,Neurogenic locus notch homolog protein 3,23006,109,1.97 [1.22-3.19],0.0057559375624053
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,NPC2,NPC intracellular cholesterol transporter 2,19445,86,1.68 [1.03-2.73],0.0365300322909324
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,NPDC1,Neural proliferation differentiation and control protein 1,22722,109,1.97 [1.32-2.94],0.0009237795802848
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,NPPB,Natriuretic peptides B,22307,105,1.31 [1.16-1.48],1.028884603508216e-05
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,NT5C1A,Cytosolic 5'-nucleotidase 1A,19716,86,2.02 [1.41-2.88],0.000122332737183
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,NTproBNP,N-terminal prohormone of brain natriuretic peptide,22722,109,1.32 [1.17-1.50],8.630596721506304e-06
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,OGN,Mimecan,22727,108,1.61 [1.11-2.32],0.0113244481840145
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,OLR1,Oxidized low-density lipoprotein receptor 1,22507,107,1.43 [1.14-1.80],0.0021919466717294
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,OMG,Oligodendrocyte-myelin glycoprotein,22609,108,0.72 [0.56-0.92],0.008300928802094
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,OSM,Oncostatin-M,22591,107,1.45 [1.14-1.83],0.0021877617353096
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,PAIP2B,Polyadenylate-binding protein-interacting protein 2B,19050,85,0.55 [0.34-0.87],0.010570158626601
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,PALM2,Paralemmin-2,19716,86,2.25 [1.47-3.45],0.0001976062422131
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,PARD3,Partitioning defective 3 homolog,19421,86,0.69 [0.49-0.97],0.0303592925630593
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,PCDH9,Protocadherin-9,19704,87,0.59 [0.36-0.98],0.0395088086727023
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,PDGFRA,Platelet-derived growth factor receptor alpha,22722,109,1.82 [1.02-3.22],0.0410393946709533
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,PEPD,Xaa-Pro dipeptidase,19789,88,0.34 [0.16-0.72],0.0050897518461992
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,PGF,Placenta growth factor,22990,109,1.94 [1.11-3.40],0.0202904108145808
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,PGLYRP1,Peptidoglycan recognition protein 1,22895,109,1.51 [1.07-2.15],0.0204474578988248
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,PHOSPHO1,Phosphoethanolamine/phosphocholine phosphatase,22521,108,2.25 [1.30-3.88],0.0035400560509921
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,PI3,Elafin,22432,107,1.64 [1.29-2.09],5.857894204605445e-05
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,PIGR,Polymeric immunoglobulin receptor,22431,107,2.13 [1.39-3.26],0.0004856652371215
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,PIK3IP1,Phosphoinositide-3-kinase-interacting protein 1,22727,108,1.95 [1.17-3.24],0.0102437685254248
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,PKD1,Polycystin-1,19770,87,2.30 [1.07-4.94],0.0326089694419736
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,PLA2G2A,"Phospholipase A2, membrane associated",22702,108,1.35 [1.05-1.74],0.0188131459910152
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,PLAUR,Urokinase plasminogen activator surface receptor,22538,107,3.59 [2.18-5.90],4.784648290318291e-07
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,PMCH,Pro-MCH,19095,82,1.22 [1.01-1.47],0.0441812208541906
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,PODXL,Podocalyxin,22609,108,0.33 [0.11-0.99],0.0484378419905797
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,PON1,Serum paraoxonase/arylesterase 1,19789,88,0.43 [0.24-0.77],0.0048692954982023
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,PPM1B,Protein phosphatase 1B,19176,84,0.56 [0.33-0.96],0.0335321322702285
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,PRDX2,Peroxiredoxin-2,19454,88,0.69 [0.49-0.98],0.0379189697869951
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,PREB,Prolactin regulatory element-binding protein,22323,107,1.77 [1.22-2.55],0.0023658115127102
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,PRELP,Prolargin,22689,107,2.21 [1.06-4.63],0.0354639117808253
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,PRG2,Bone marrow proteoglycan,19775,88,1.46 [1.01-2.13],0.0459429144251602
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,PRKAG3,5'-AMP-activated protein kinase subunit gamma-3,19237,83,0.43 [0.20-0.95],0.0363021851060582
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,PRTG,Protogenin,22917,109,1.95 [1.02-3.76],0.0447081004931202
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,PSMA1,Proteasome subunit alpha type-1,22178,107,0.64 [0.42-0.98],0.0408643121654904
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,PSMC3,26S proteasome regulatory subunit 6A,19082,85,0.48 [0.24-0.99],0.0468628814264628
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,PTH1R,Parathyroid hormone/parathyroid hormone-related peptide receptor,22700,107,1.44 [1.04-1.98],0.0281607732549534
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,PTX3,Pentraxin-related protein PTX3,22700,107,1.72 [1.15-2.58],0.0085656246166164
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,PVR,Poliovirus receptor,22930,109,1.59 [1.05-2.41],0.0286741138465983
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,PYY,Peptide YY,19095,82,1.31 [1.09-1.58],0.0049225985504293
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,QPCT,Glutaminyl-peptide cyclotransferase,22741,107,2.30 [1.25-4.23],0.0072018699456567
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,QSOX1,Sulfhydryl oxidase 1,19398,88,1.63 [1.29-2.06],3.744022201221275e-05
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,RABEP1,Rab GTPase-binding effector protein 1,19321,84,0.68 [0.51-0.91],0.0094961347778152
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,RAD51,DNA repair protein RAD51 homolog 1,19421,86,0.59 [0.35-1.00],0.0490563188963881
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,RAPGEF2,Rap guanine nucleotide exchange factor 2,19421,86,0.62 [0.40-0.97],0.0375213932425547
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,RARRES1,Retinoic acid receptor responder protein 1,22178,107,1.53 [1.06-2.21],0.0216856100215449
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,RBFOX3,RNA binding protein fox-1 homolog 3,19729,85,1.86 [1.29-2.67],0.000818114617387
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,REG1A,Lithostathine-1-alpha,22605,106,1.55 [1.16-2.08],0.0031605014821052
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,REG1B,Lithostathine-1-beta,23006,109,1.43 [1.10-1.85],0.0070165800935195
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,REG3A,Regenerating islet-derived protein 3-alpha,23006,109,1.44 [1.14-1.82],0.0022125079100783
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,REG4,Regenerating islet-derived protein 4,22723,107,1.55 [1.15-2.08],0.0043299807860104
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,RELT,Tumor necrosis factor receptor superfamily member 19L,22727,108,1.70 [1.01-2.87],0.0454049037869194
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,RET,Proto-oncogene tyrosine-protein kinase receptor Ret,22609,108,0.53 [0.34-0.83],0.0050798458731394
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,RETN,Resistin,22684,107,1.74 [1.27-2.40],0.0006293836895954
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,RNASE6,Ribonuclease K6,19663,88,1.56 [1.03-2.38],0.0377815928763594
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,RNASEH2A,Ribonuclease H2 subunit A,19729,85,0.55 [0.31-0.96],0.0339752514672554
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,RNASET2,Ribonuclease T2,22901,108,2.28 [1.30-4.02],0.0042963328290574
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,ROR1,Inactive tyrosine-protein kinase transmembrane receptor ROR1,22722,109,1.86 [1.12-3.10],0.016780565710101
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,RSPO3,R-spondin-3,22917,109,2.64 [1.58-4.40],0.0002002124272387
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,S100A11,Protein S100-A11,22550,108,1.40 [1.06-1.84],0.0174144451779685
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,S100A13,Protein S100-A13,19176,84,1.79 [1.13-2.81],0.0122022534574211
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,SAA4,Serum amyloid A-4 protein,19786,88,1.65 [1.21-2.25],0.0014612949658832
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,SCARB2,Lysosome membrane protein 2,22077,107,1.86 [1.19-2.93],0.006978601948261
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,SCARF2,Scavenger receptor class F member 2,22930,109,2.37 [1.37-4.12],0.0021064143840007
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,SCG2,Secretogranin-2,22822,109,1.83 [1.12-2.99],0.0153175431854589
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,SCRIB,Protein scribble homolog,19224,81,0.73 [0.54-1.00],0.0486522837029458
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,SDC4,Syndecan-4,22722,109,0.70 [0.49-0.99],0.0432956590319479
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,SELP,P-selectin,22832,108,0.71 [0.52-0.97],0.0317274818463518
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,SERPINA11,Serpin A11,23006,109,1.80 [1.19-2.73],0.005149846297272
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,SFRP1,Secreted frizzled-related protein 1,22439,108,1.44 [1.01-2.05],0.0459359162072791
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,SFTPA2,Pulmonary surfactant-associated protein A2,22178,107,1.49 [1.11-2.00],0.0087514536114334
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,SHH,Sonic hedgehog protein,19176,84,0.56 [0.33-0.95],0.0312986296957974
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,SHISA5,Protein shisa-5,19775,88,1.77 [1.08-2.90],0.0239512213625972
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,SIGLEC1,Sialoadhesin,22802,107,1.48 [1.00-2.19],0.0479525074689636
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,SLAMF1,Signaling lymphocytic activation molecule,22323,107,1.36 [1.01-1.82],0.0398051625280648
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,SMOC1,SPARC-related modular calcium-binding protein 1,22917,109,1.94 [1.21-3.12],0.0060620716417025
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,SNAPIN,SNARE-associated protein Snapin,19729,85,0.62 [0.43-0.92],0.0162197749381731
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,SNCG,Gamma-synuclein,22521,108,1.41 [1.08-1.83],0.0107967117001157
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,SPART,Spartin,19321,84,0.73 [0.54-0.97],0.0299933610035692
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,SPINK1,Serine protease inhibitor Kazal-type 1,22727,108,1.98 [1.42-2.77],6.616852478118775e-05
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,SPINK4,Serine protease inhibitor Kazal-type 4,22700,107,1.41 [1.12-1.78],0.0032673037618264
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,SPINK5,Serine protease inhibitor Kazal-type 5,22727,108,1.73 [1.10-2.72],0.0179789448636362
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,SPINT1,Kunitz-type protease inhibitor 1,22643,108,1.84 [1.03-3.29],0.0402581915035544
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,SPON1,Spondin-1,22723,107,2.13 [1.43-3.17],0.000202776812292
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,SPP1,Osteopontin,22972,109,1.58 [1.10-2.25],0.0128189889262865
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,SRPX,Sushi repeat-containing protein SRPX,19770,87,1.83 [1.06-3.16],0.0303747526389956
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,SSC4D,Scavenger receptor cysteine-rich domain-containing group B protein,22691,109,0.87 [0.75-1.00],0.042393783569818
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,ST13,Hsc70-interacting protein,19321,84,0.65 [0.44-0.95],0.0273181902074728
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,STC2,Stanniocalcin-2,22696,108,2.06 [1.01-4.23],0.0477093366850554
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,STX6,Syntaxin-6,22178,107,0.71 [0.51-0.98],0.0401347389755351
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,SUGP1,SURP and G-patch domain-containing protein 1,19704,87,0.46 [0.25-0.83],0.0105648611282887
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,19421,86,0.81 [0.66-0.99],0.0391249160686614
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,TACSTD2,Tumor-associated calcium signal transducer 2,20120,93,2.17 [1.19-3.97],0.011552203213051
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,TCL1A,T-cell leukemia/lymphoma protein 1A,22492,108,0.78 [0.66-0.92],0.0026267529772879
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,TEX101,Testis-expressed protein 101,19237,83,0.69 [0.49-0.98],0.0401082346857652
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,TFF1,Trefoil factor 1,22619,108,1.27 [1.05-1.53],0.0116835987508773
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,TFF2,Trefoil factor 2,22768,107,1.55 [1.19-2.01],0.0009839409882055
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,TFF3,Trefoil factor 3,22723,108,1.63 [1.25-2.13],0.0003146491329346
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,TGFA,Protransforming growth factor alpha,22700,107,1.52 [1.09-2.12],0.0134603655053234
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,TGFBR2,TGF-beta receptor type-2,22780,108,1.72 [1.14-2.60],0.0094493220373406
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,TGFBR3,Transforming growth factor beta receptor type 3,23006,109,1.93 [1.12-3.31],0.0179024611365779
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,THBS2,Thrombospondin-2,22727,108,1.75 [1.21-2.55],0.0033178176120819
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,THBS4,Thrombospondin-4,22762,108,1.63 [1.13-2.34],0.0086068864530984
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,TIMD4,T-cell immunoglobulin and mucin domain-containing protein 4,22832,108,1.73 [1.19-2.50],0.0040295498698871
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,TIMP4,Metalloproteinase inhibitor 4,22727,108,1.72 [1.18-2.52],0.0050798812047964
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,TNC,Tenascin,22832,108,1.54 [1.10-2.16],0.0116660031831097
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,TNFRSF10A,Tumor necrosis factor receptor superfamily member 10A,22521,108,1.58 [1.06-2.37],0.0261519795417503
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,TNFRSF10B,Tumor necrosis factor receptor superfamily member 10B,22521,108,1.30 [1.05-1.63],0.0179755755598108
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,TNFRSF11A,Tumor necrosis factor receptor superfamily member 11A,22990,109,1.52 [1.03-2.26],0.0347379191589738
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,TNFRSF11B,Tumor necrosis factor receptor superfamily member 11B,22689,107,2.24 [1.33-3.79],0.0025558188952886
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,TNFRSF13B,Tumor necrosis factor receptor superfamily member 13B,22723,107,1.62 [1.13-2.31],0.0082271180321298
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,TNFRSF19,Tumor necrosis factor receptor superfamily member 19,22917,109,1.62 [1.04-2.54],0.0339121067775914
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,TNFRSF1A,Tumor necrosis factor receptor superfamily member 1A,22727,108,2.12 [1.33-3.39],0.0016146380249208
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,TNFRSF1B,Tumor necrosis factor receptor superfamily member 1B,22727,108,1.52 [1.08-2.14],0.0161013538608929
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,TNFRSF21,Tumor necrosis factor receptor superfamily member 21,22930,109,1.77 [1.00-3.14],0.0494858046306501
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,TNFRSF6B,Tumor necrosis factor receptor superfamily member 6B,22521,108,1.38 [1.06-1.78],0.0156671875760116
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,TNFSF10,Tumor necrosis factor ligand superfamily member 10,22990,109,0.45 [0.23-0.87],0.0167497871162125
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,TNFSF13B,Tumor necrosis factor ligand superfamily member 13B,22970,109,1.77 [1.02-3.06],0.0427473473545578
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,TNNI3,"Troponin I, cardiac muscle",22307,105,1.25 [1.01-1.54],0.0424204609088479
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,TSC1,Hamartin,19176,84,0.66 [0.43-1.00],0.0498245635017208
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,TTF2,Transcription termination factor 2,19237,83,0.57 [0.35-0.91],0.0176759908006908
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,UBQLN3,Ubiquilin-3,19095,82,1.48 [1.16-1.88],0.0015100320851528
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,UMOD,Uromodulin,22928,109,0.70 [0.53-0.94],0.0162010053379677
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,VCAM1,Vascular cell adhesion protein 1,22798,108,1.91 [1.08-3.38],0.0268556593422868
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,VSIG4,V-set and immunoglobulin domain-containing protein 4,22696,108,1.76 [1.21-2.56],0.0030538997821722
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,WFDC2,WAP four-disulfide core domain protein 2,21588,101,1.95 [1.38-2.75],0.000158410326992
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,WIF1,Wnt inhibitory factor 1,22917,109,1.92 [1.19-3.11],0.0079171646431265
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,WNT9A,Protein Wnt-9a,22323,107,1.73 [1.02-2.95],0.0434770414957386
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,XG,Glycoprotein Xg,22902,109,1.65 [1.03-2.63],0.0365233550350169
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,YAP1,Transcriptional coactivator YAP1,19716,86,3.28 [1.78-6.04],0.0001339940082609
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,YOD1,Ubiquitin thioesterase OTU1,19095,82,0.70 [0.49-0.99],0.0441400758999687
"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,ZNF830,Zinc finger protein 830,19698,87,1.31 [1.07-1.61],0.0098766032151971
